TY  - GEN
AU  - Markowitz,M
AU  - Conant,M
AU  - Hurley,A
AU  - Schluger,R
AU  - Duran,M
AU  - Peterkin,J
AU  - Chapman,S
AU  - Patick,A
AU  - Hendricks,A
AU  - Yuen,G J
AU  - Hoskins,W
AU  - Clendeninn,N
AU  - Ho,D D
TI  - A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infection
SN  - 0022-1899
PY  - 1998///0618
KW  - Adult
KW  - Anti-HIV Agents
KW  - adverse effects
KW  - CD4 Lymphocyte Count
KW  - Drug Evaluation
KW  - Drug Resistance, Microbial
KW  - Female
KW  - Follow-Up Studies
KW  - HIV Infections
KW  - drug therapy
KW  - HIV Protease Inhibitors
KW  - HIV-1
KW  - drug effects
KW  - Humans
KW  - Male
KW  - Nelfinavir
KW  - RNA, Viral
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1086/515312
ER  -